Bionomics Ltd (BNOX)
1.01
+0.04
(+4.11%)
USD |
NASDAQ |
May 24, 16:00
1.03
+0.02
(+1.98%)
After-Hours: 20:00
Bionomics Enterprise Value: 1.437M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | 1.437M |
| May 23, 2024 | 1.010M |
| May 22, 2024 | 3.469M |
| May 21, 2024 | 3.255M |
| May 20, 2024 | 0.4392M |
| May 17, 2024 | 0.2862M |
| May 16, 2024 | 0.5049M |
| May 15, 2024 | 0.475M |
| May 14, 2024 | 0.5824M |
| May 13, 2024 | 0.4948M |
| May 10, 2024 | 0.807M |
| May 09, 2024 | 0.9385M |
| May 08, 2024 | 0.9161M |
| May 07, 2024 | 0.9022M |
| May 06, 2024 | 1.200M |
| May 03, 2024 | 0.9022M |
| May 02, 2024 | 0.576M |
| May 01, 2024 | 0.3761M |
| April 30, 2024 | 0.7952M |
| April 29, 2024 | 1.437M |
| April 26, 2024 | 1.330M |
| April 25, 2024 | 0.9695M |
| April 24, 2024 | 0.7621M |
| April 23, 2024 | 0.5087M |
| April 22, 2024 | 0.9011M |
| Date | Value |
|---|---|
| April 19, 2024 | 1.110M |
| April 18, 2024 | 1.116M |
| April 17, 2024 | 0.8926M |
| April 16, 2024 | 0.93M |
| April 15, 2024 | 1.105M |
| April 12, 2024 | 1.276M |
| April 11, 2024 | 1.330M |
| April 10, 2024 | 1.330M |
| April 09, 2024 | 1.544M |
| April 08, 2024 | 1.599M |
| April 05, 2024 | 1.437M |
| April 04, 2024 | 1.274M |
| April 03, 2024 | 1.330M |
| April 02, 2024 | 1.227M |
| April 01, 2024 | 1.330M |
| March 28, 2024 | 1.651M |
| March 27, 2024 | 1.651M |
| March 26, 2024 | 1.865M |
| March 25, 2024 | 0.5824M |
| March 22, 2024 | 0.9022M |
| March 21, 2024 | 1.330M |
| March 20, 2024 | 1.773M |
| March 19, 2024 | 1.758M |
| March 18, 2024 | 1.865M |
| March 15, 2024 | 1.651M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.197M
Minimum
Mar 30 2023
71.35M
Maximum
Dec 21 2021
17.78M
Average
11.75M
Median
Jan 31 2023
Enterprise Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 5.180M |
| Immutep Ltd | -- |
| Opthea Ltd | 108.05M |
| Mesoblast Ltd | -- |